Tim Scallen

Tim Scallen is the Chief Executive Officer of Bailey & Company, a Nashville-based merchant banking platform (founded 2005 by Jeff and Jack Bailey, healthcare-exclusive since 2012) that pairs a healthcare investment-banking practice with a principal-investing arm serving the lower-middle-market. He was appointed CEO on May 14, 2024, joining the firm's board of directors at the same time. He originally joined Bailey (then "Bailey Southwell & Co.") in 2020 as Chief Operating Officer and Managing Partner of the firm's principal-investing business, where he led BSC Capital Partners, its affiliated fund making minority investments in growth and late-stage healthcare and tech-enabled services companies.

Before Bailey, Scallen spent roughly six years (joining in 2014) as a Principal at TT Capital Partners — the growth-equity investing arm that grew out of the TripleTree merchant bank. There his work spanned growth-equity investing, late-stage buyouts, and subordinated lending, and he acted variously as investor, board member, and advisor to healthcare-technology and information/analytics companies. This is the role reflected in the source stub's "triple-tree.com" contact details, which now appear to be legacy.

Earlier in his career, Scallen was an associate at Norwest Equity Partners and held a position at Sankaty Advisors (the credit affiliate now known as Bain Capital Credit). Across these firms he accumulated more than a decade of experience in portfolio management, fundraising, and deal execution. He holds a Bachelor of Business Administration from the University of Notre Dame.

• Focus on healthcare technology and tech-enabled healthcare services, plus healthcare information/analytics — segments he has covered as an investor, operator, board member, and advisor.
• Backs growth and late-stage companies, typically via minority equity stakes (the BSC Capital Partners model) — distinct from early seed/angel investing.
• Brings a blended operating + investing perspective; Bailey positions itself around the "intricacies of lower-middle-market healthcare," connecting capital providers, healthcare strategics, and industry executives.
• Values fit with established management teams and companies with real traction in healthcare services/technology, rather than pre-revenue concepts.
• On his CEO appointment he said: *"I am honored to accept this position and grateful to the firm for entrusting me with this role and showing confidence in my ability."*